Design Therapeutics (DSGN) grants director David Shapiro 30,000 options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Design Therapeutics, Inc. director David Shapiro received a stock option grant covering 30,000 shares of common stock. The option has an exercise price of $10.55 per share and expires on June 8, 2036. The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026, and will in any case be fully vested by the date of the company’s next annual meeting of stockholders. This is a compensation-related award, not an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Shapiro David
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 30,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 30,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 30,000 options
Exercise price: $10.55 per share
Expiration date: June 8, 2036
+2 more
5 metrics
Option grant size
30,000 options
Stock Option (right to buy) granted to director David Shapiro
Exercise price
$10.55 per share
Conversion or exercise price for the stock options
Expiration date
June 8, 2036
Option expiration for the 30,000-share grant
Underlying shares
30,000 shares
Underlying common stock covered by the option grant
Vesting period
12 months after June 9, 2026
Equal monthly vesting with full vesting by next annual meeting
Key Terms
Stock Option (right to buy), exercise price, vest in equal monthly installments, annual meeting of stockholders
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 10.5500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in equal monthly installments financial
"The shares subject to the option vest in equal monthly installments over 12 months"
annual meeting of stockholders financial
"fully vested on the date of the Company's next annual meeting of stockholders"
FAQ
What did David Shapiro receive in this Design Therapeutics (DSGN) Form 4 filing?
David Shapiro received a stock option grant for 30,000 shares of Design Therapeutics common stock. The options are a compensation award, giving him the right to buy shares at a fixed exercise price if he chooses in the future.
What is the exercise price of David Shapiro’s Design Therapeutics stock options?
The stock options have an exercise price of $10.55 per share. This means Shapiro can buy up to 30,000 shares at $10.55 each, regardless of the market price, once the options vest and before they expire in 2036.
How do David Shapiro’s Design Therapeutics options vest over time?
The options vest in equal monthly installments over 12 months following June 9, 2026. This monthly vesting schedule gradually makes more options exercisable and aligns Shapiro’s long-term incentives with the company’s performance over that year.
When will David Shapiro’s Design Therapeutics options be fully vested at the latest?
All 30,000 option shares will be fully vested by the date of Design Therapeutics’ next annual meeting of stockholders. This provision ensures full vesting even if the monthly vesting schedule would otherwise extend beyond that meeting date.
When do David Shapiro’s Design Therapeutics stock options expire?
The options expire on June 8, 2036. After that date, any unexercised options become worthless. The long expiration term gives Shapiro many years to decide if and when to exercise, depending on Design Therapeutics’ share price and his plans.